Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole-Reference-Cited by-同舟云学术

Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole

Published:1999-02 Issue:2 Volume:47 Page:145-150
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Brynne ¹,Böttiger ²,Hallén ¹,Bertilsson ²

Affiliation:

1. Department of Clinical Pharmacology, Pharmacia & Upjohn AB, SE‐112 87 Stockholm

2. Department of Medical Laboratory Sciences and Technology, Division of Clinical Pharmacology at the Karolinska Institute, Huddinge University Hospital, SE‐141 86 Huddinge, Sweden

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2125.1999.00865.x

Reference36 articles.

1. Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study

2. Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation

3. Dose-ranging study of tolterodine in patients with detrusor hyperreflexia

4. Tolterodine – a new bladder-selective antimuscarinic agent

5. Pharmacokinetics and pharmacodynamics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity.;Brynne N;Int J Clin Pharmacol Ther,1997

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hansen solubility parameters and quality-by-design oriented optimized cationic nanoemulsion for transdermal drug delivery of tolterodine tartrate;International Journal of Pharmaceutics;2024-10

2. Use of Cocktail Probe Drugs for Indexing Cytochrome P450 Enzymes in Clinical Pharmacology Studies – Review of Case Studies;Drug Metabolism Letters;2019-04-30

3. Lessons from Cuba for Global Precision Medicine: CYP2D6 Genotype Is Not a Robust Predictor of CYP2D6 Ultrarapid Metabolism;OMICS: A Journal of Integrative Biology;2017-01

4. Pharmacokinetic drug interaction study between overactive bladder drugs mirabegron and tolterodine in Japanese healthy postmenopausal females;Drug Metabolism and Pharmacokinetics;2016-12

5. CombiCap: A novel drug formulation for the basel phenotyping cocktail;International Journal of Pharmaceutics;2016-10